XERIS PHARMACEUTICALS INC

Quarterly Report for period ending 2021-06-30

Quarterly Report for period ending 2021-03-31

Annual Report for period ending 2020-12-31

Quarterly Report for period ending 2020-09-30

Quarterly Report for period ending 2020-06-30

Quarterly Report for period ending 2020-03-31

Annual Report for period ending 2019-12-31

Quarterly Report for period ending 2019-09-30

Quarterly Report for period ending 2019-06-30

Quarterly Report for period ending 2019-03-31

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Notice of termination of registration of a class of securities under Section 12(b)

Notice of Effectiveness

Post-effective amendment to a registration statement that is not immediately effective upon filing

Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities

Application for designation of a new trustee under the Trust Indenture Act

Notice of Effectiveness

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Notice of Effectiveness

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Sessa Capital (Master), L.P.: Major Shareholders

HALKUFF DAWN: Statement of changes in beneficial ownership of securities

Schmid John P.: Statement of changes in beneficial ownership of securities

Edick Paul R: Statement of changes in beneficial ownership of securities

Hecht Beth: Statement of changes in beneficial ownership of securities

Pieper Steven: Statement of changes in beneficial ownership of securities

Shannon John Patrick Jr: Statement of changes in beneficial ownership of securities

SHERMAN JEFFREY W: Statement of changes in beneficial ownership of securities

PERSKY MARLA: Statement of changes in beneficial ownership of securities

BORMANN-KENNEDY BARBARA-JEAN ANNE: Statement of changes in beneficial ownership of securities

Post-effective amendment to a S-8 registration statement

Post-effective amendment to a S-8 registration statement

Post-effective amendment to a S-8 registration statement

Post-effective amendment to a S-8 registration statement

Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Definitive proxy statement relating to a merger, acquisition, or disposition

Definitive proxy statements

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive proxy statements

Preliminary proxy statement not related to a contested matter or merger/acquisition

Definitive proxy statements

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.